<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ANTIGENICS INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware 06-1562417
----------------------- -------------------
(State of Incorporation (IRS Employer
or Organization) Identification No.)
630 Fifth Avenue, Suite 2100
New York, New York 10111
- ---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. [ ]
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. [X]
Securities Act registration statement file number to which this form
relates: 333-91747
-------------
(If Applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
None None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value
-----------------------------
(Title of Class)
<PAGE> 2
Item 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
We incorporate by reference the description of our common stock, $.01
par value per share, appearing under the headings "Description of Capital Stock"
and "Shares Eligible for Future Sale" in our Registration Statement on Form S-1,
including any amendments thereto (File No. 333-91747).
Item 2. EXHIBITS.
The following exhibits are filed as part of this registration
statement:
3.1* Certificate of Incorporation of Antigenics.
3.2* By-laws of Antigenics.
4.2* Form of Warrant to Purchase Common Stock, together with a list
of holders.
4.3* Form of Subscription Agreement, as amended, together with a
list of parties thereto.
- -----------------
* Incorporated by reference to the Exhibits of the same number to the
Registrant's Registration Statement on Form S-1, including any
amendments thereto (File No. 333-91747).
2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
ANTIGENICS INC.
Date: January 24, 2000 By: /s/ Garo H. Armen
--------------------------------
Garo H. Armen
President and Chief Executive Officer
3
